More than 100 million people in the United States suffer from metabolic dysfunction-associated steatotic liver disease (MASLD ...

In January, the U.S. Food and Drug Administration (FDA) issued its first guidance on the use of artificial intelligence (AI)[1] models in drug development and in regulatory submissions titled, ...

A Google DeepMind invention that uses artificial intelligence (AI) to predict how DNA mutations behave could have a ...

Eli Lilly has developed artificial intelligence models that can help predict the behavior of potential drug candidates, based on the data the drugmaker has collected over the last two decades and at ...

Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, received an up to $21M award to lead a project to develop next-generation models of drug toxicity to advance safer ...

Google gave an update on how it is using AI to advance science and build products at its recent Check Up event. In a blog post, Google's chief health officer, Dr. Karen DeSalvo, said that since the ...

Together with robust data-driven modeling, rethinking regulation and data use could push forward a notoriously challenging ...

For decades, the pharmaceutical industry has discussed moving away from in vivo models in preclinical research. Now, it’s more than a conversation. The FDA’s roadmap for reducing animal testing, ...

To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...

The Medicare Innovation Center has proposed two drug pricing models that would lower the cost of certain drugs to reflect international prices, which are often significantly lower than what U.S.